Nall Michael W. 4
4 · BIOCEPT INC · Filed Sep 2, 2021
Insider Transaction Report
Form 4
BIOCEPT INCBIOC
Nall Michael W.
DirectorCEO AND PRESIDENT
Transactions
- Award
Employee Stock Option (right to buy)
2021-09-02+100,000→ 100,000 totalExercise: $3.76Exp: 2031-09-01→ Common Stock (100,000 underlying) - Award
Performance-Based Employee Stock Option (right to buy)
2021-09-02+80,000→ 80,000 totalExercise: $3.76Exp: 2031-09-01→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 9/2/21 until fully vested on 9/2/2024.
- [F2]1/36th of the shares subject to the option shall vest monthly, commencing upon the Issuer's achievement of a specified corporate milestone.